世界のブピバカインリポソーム注射懸濁液市場:成長動向・競争分析2020-2026

【英語タイトル】Global Bupivacaine Liposome Injectable Suspension Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00408)・商品コード:QYR20AP00408
・発行会社(調査会社):QYResearch
・発行日:2020年3月25日(※2024年版があります。お問い合わせください)
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、ブピバカインリポソーム注射懸濁液の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ブピバカインリポソーム注射懸濁液のグローバル市場動向、メーカー別競争状況、種類別市場規模(20ml、10ml)、用途別市場規模(獣医、人間)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ブピバカインリポソーム注射懸濁液の種類別市場2015-2026:20ml、10ml
・ブピバカインリポソーム注射懸濁液の用途別市場2015-2026:獣医、人間
・ブピバカインリポソーム注射懸濁液の北米市場分析
・ブピバカインリポソーム注射懸濁液のアジア市場分析
・ブピバカインリポソーム注射懸濁液の中南米市場分析
・ブピバカインリポソーム注射懸濁液の中東・アフリカ市場分析
・関連企業情報:Pacira Pharmaceuticals
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Liposomal bupivacaine has been approved by the US Food and Drug Administration for local infiltration for pain relief after bunionectomy and hemorrhoidectomy. In 2019, the global Bupivacaine Liposome Injectable Suspension market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Bupivacaine Liposome Injectable Suspension.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Bupivacaine Liposome Injectable Suspension market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Bupivacaine Liposome Injectable Suspension market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Bupivacaine Liposome Injectable Suspension market. Readers of the report can become informed about current and future trends of the global Bupivacaine Liposome Injectable Suspension market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Bupivacaine Liposome Injectable Suspension markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Bupivacaine Liposome Injectable Suspension market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Bupivacaine Liposome Injectable Suspension market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Bupivacaine Liposome Injectable Suspension market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Bupivacaine Liposome Injectable Suspension market is segmented into
20ml
10ml

Market Segment by Application, the Bupivacaine Liposome Injectable Suspension market is segmented into
Veterinary
Human

This report includes the following manufacturers; we can also add the other companies as you want.
Pacira Pharmaceuticals

The study objectives are:
To analyze and research the global Bupivacaine Liposome Injectable Suspension status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Bupivacaine Liposome Injectable Suspension manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bupivacaine Liposome Injectable Suspension are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Bupivacaine Liposome Injectable Suspension Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Bupivacaine Liposome Injectable Suspension Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 20ml
1.3.3 10ml
1.4 Market Segment by Application
1.4.1 Global Bupivacaine Liposome Injectable Suspension Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Veterinary
1.4.3 Human
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Bupivacaine Liposome Injectable Suspension Revenue (2015-2026)
2.1.1 Global Bupivacaine Liposome Injectable Suspension Revenue (2015-2026)
2.1.2 Global Bupivacaine Liposome Injectable Suspension Sales (2015-2026)
2.2 Bupivacaine Liposome Injectable Suspension Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Bupivacaine Liposome Injectable Suspension Sales by Regions (2015-2020)
2.2.2 Global Bupivacaine Liposome Injectable Suspension Revenue by Regions (2015-2020)
2.3 Global Top Bupivacaine Liposome Injectable Suspension Regions (Countries) Ranking by Market Size
2.4 Bupivacaine Liposome Injectable Suspension Industry Trends
2.4.1 Bupivacaine Liposome Injectable Suspension Market Top Trends
2.4.2 Market Drivers
2.4.3 Bupivacaine Liposome Injectable Suspension Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Bupivacaine Liposome Injectable Suspension Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Bupivacaine Liposome Injectable Suspension Manufacturers by Sales (2015-2020)
3.1.1 Global Bupivacaine Liposome Injectable Suspension Sales by Manufacturers (2015-2020)
3.1.2 Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Bupivacaine Liposome Injectable Suspension Sales in 2019
3.2 Global Top Manufacturers Bupivacaine Liposome Injectable Suspension by Revenue
3.2.1 Global Bupivacaine Liposome Injectable Suspension Revenue by Manufacturers (2015-2020)
3.2.2 Global Bupivacaine Liposome Injectable Suspension Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bupivacaine Liposome Injectable Suspension Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bupivacaine Liposome Injectable Suspension as of 2019)
3.4 Global Bupivacaine Liposome Injectable Suspension Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Bupivacaine Liposome Injectable Suspension Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Bupivacaine Liposome Injectable Suspension Market
3.7 Key Manufacturers Bupivacaine Liposome Injectable Suspension Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Bupivacaine Liposome Injectable Suspension Historic Market Review by Type (2015-2020)
4.1.2 Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Type (2015-2020)
4.1.3 Global Bupivacaine Liposome Injectable Suspension Revenue Market Share by Type (2015-2020)
4.1.4 Bupivacaine Liposome Injectable Suspension Price by Type (2015-2020)
4.1 Global Bupivacaine Liposome Injectable Suspension Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Bupivacaine Liposome Injectable Suspension Sales Forecast by Type (2021-2026)
4.2.3 Global Bupivacaine Liposome Injectable Suspension Revenue Forecast by Type (2021-2026)
4.2.4 Bupivacaine Liposome Injectable Suspension Price Forecast by Type (2021-2026)

5 Global Bupivacaine Liposome Injectable Suspension Market Size by Application
5.1 Global Bupivacaine Liposome Injectable Suspension Historic Market Review by Application (2015-2020)
5.1.2 Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Application (2015-2020)
5.1.3 Global Bupivacaine Liposome Injectable Suspension Revenue Market Share by Application (2015-2020)
5.1.4 Bupivacaine Liposome Injectable Suspension Price by Application (2015-2020)
5.2 Global Bupivacaine Liposome Injectable Suspension Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Bupivacaine Liposome Injectable Suspension Sales Forecast by Application (2021-2026)
5.2.3 Global Bupivacaine Liposome Injectable Suspension Revenue Forecast by Application (2021-2026)
5.2.4 Bupivacaine Liposome Injectable Suspension Price Forecast by Application (2021-2026)

6 North America
6.1 North America Bupivacaine Liposome Injectable Suspension Breakdown Data by Company
6.2 North America Bupivacaine Liposome Injectable Suspension Breakdown Data by Type
6.3 North America Bupivacaine Liposome Injectable Suspension Breakdown Data by Application
6.4 North America Bupivacaine Liposome Injectable Suspension Breakdown Data by Countries
6.4.1 North America Bupivacaine Liposome Injectable Suspension Sales by Countries
6.4.2 North America Bupivacaine Liposome Injectable Suspension Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Bupivacaine Liposome Injectable Suspension Breakdown Data by Company
7.2 Europe Bupivacaine Liposome Injectable Suspension Breakdown Data by Type
7.3 Europe Bupivacaine Liposome Injectable Suspension Breakdown Data by Application
7.4 Europe Bupivacaine Liposome Injectable Suspension Breakdown Data by Countries
7.4.1 Europe Bupivacaine Liposome Injectable Suspension Sales by Countries
7.4.2 Europe Bupivacaine Liposome Injectable Suspension Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Bupivacaine Liposome Injectable Suspension Breakdown Data by Company
8.2 Asia Pacific Bupivacaine Liposome Injectable Suspension Breakdown Data by Type
8.3 Asia Pacific Bupivacaine Liposome Injectable Suspension Breakdown Data by Application
8.4 Asia Pacific Bupivacaine Liposome Injectable Suspension Breakdown Data by Regions
8.4.1 Asia Pacific Bupivacaine Liposome Injectable Suspension Sales by Regions
8.4.2 Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Bupivacaine Liposome Injectable Suspension Breakdown Data by Company
9.2 Latin America Bupivacaine Liposome Injectable Suspension Breakdown Data by Type
9.3 Latin America Bupivacaine Liposome Injectable Suspension Breakdown Data by Application
9.4 Latin America Bupivacaine Liposome Injectable Suspension Breakdown Data by Countries
9.4.1 Latin America Bupivacaine Liposome Injectable Suspension Sales by Countries
9.4.2 Latin America Bupivacaine Liposome Injectable Suspension Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Bupivacaine Liposome Injectable Suspension Breakdown Data by Type
10.2 Middle East and Africa Bupivacaine Liposome Injectable Suspension Breakdown Data by Application
10.3 Middle East and Africa Bupivacaine Liposome Injectable Suspension Breakdown Data by Countries
10.3.1 Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Countries
10.3.2 Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Pacira Pharmaceuticals
11.1.1 Pacira Pharmaceuticals Corporation Information
11.1.2 Pacira Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Products and Services
11.1.5 Pacira Pharmaceuticals SWOT Analysis
11.1.6 Pacira Pharmaceuticals Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Bupivacaine Liposome Injectable Suspension Sales Channels
12.2.2 Bupivacaine Liposome Injectable Suspension Distributors
12.3 Bupivacaine Liposome Injectable Suspension Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Bupivacaine Liposome Injectable Suspension Sales Forecast (2021-2026)
13.1.1 Global Bupivacaine Liposome Injectable Suspension Sales Forecast by Regions (2021-2026)
13.1.2 Global Bupivacaine Liposome Injectable Suspension Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Bupivacaine Liposome Injectable Suspension Sales Forecast (2021-2026)
13.2.2 North America Bupivacaine Liposome Injectable Suspension Revenue Forecast (2021-2026)
13.2.3 North America Bupivacaine Liposome Injectable Suspension Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Bupivacaine Liposome Injectable Suspension Sales Forecast (2021-2026)
13.3.2 Europe Bupivacaine Liposome Injectable Suspension Revenue Forecast (2021-2026)
13.3.3 Europe Bupivacaine Liposome Injectable Suspension Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Bupivacaine Liposome Injectable Suspension Sales Forecast (2021-2026)
13.4.2 Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Bupivacaine Liposome Injectable Suspension Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Bupivacaine Liposome Injectable Suspension Sales Forecast (2021-2026)
13.5.2 Latin America Bupivacaine Liposome Injectable Suspension Revenue Forecast (2021-2026)
13.5.3 Latin America Bupivacaine Liposome Injectable Suspension Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Bupivacaine Liposome Injectable Suspension Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Bupivacaine Liposome Injectable Suspension Key Market Segments
Table 2. Ranking of Global Top Bupivacaine Liposome Injectable Suspension Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bupivacaine Liposome Injectable Suspension Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of 20ml
Table 5. Major Manufacturers of 10ml
Table 6. Global Bupivacaine Liposome Injectable Suspension Market Share by Application 2019-2025 (K Units)
Table 7. Global Bupivacaine Liposome Injectable Suspension Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Bupivacaine Liposome Injectable Suspension Sales by Regions 2015-2020 (K Units)
Table 9. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Regions 2015-2020
Table 10. Global Bupivacaine Liposome Injectable Suspension Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Bupivacaine Liposome Injectable Suspension Revenue Market Share by Regions 2015-2020
Table 12. Top Bupivacaine Liposome Injectable Suspension Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Bupivacaine Liposome Injectable Suspension Key Drivers: Impact Analysis (2021-2026)
Table 15. Bupivacaine Liposome Injectable Suspension Key Challenges
Table 16. Main Points Interviewed from Key Bupivacaine Liposome Injectable Suspension Players: Views for Future
Table 17. Global Bupivacaine Liposome Injectable Suspension Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Bupivacaine Liposome Injectable Suspension Sales Share by Manufacturers (2015-2020)
Table 19. Bupivacaine Liposome Injectable Suspension Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Bupivacaine Liposome Injectable Suspension Revenue Share by Manufacturers (2015-2020)
Table 21. Global Bupivacaine Liposome Injectable Suspension Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bupivacaine Liposome Injectable Suspension as of 2019)
Table 23. Key Manufacturers Bupivacaine Liposome Injectable Suspension Average Selling Price (ASP) (2015-2020) (US$/Unit)
Table 24. Key Manufacturers Bupivacaine Liposome Injectable Suspension Plants/Factories Distribution
Table 25. Key Manufacturers Bupivacaine Liposome Injectable Suspension Area Served
Table 26. Date of Key Manufacturers Enter into Bupivacaine Liposome Injectable Suspension Market
Table 27. Key Manufacturers Bupivacaine Liposome Injectable Suspension Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global 20ml Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global 10ml Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Bupivacaine Liposome Injectable Suspension Sales (K Units) by Type (2015-2020)
Table 32. Global Bupivacaine Liposome Injectable Suspension Sales Share by Type (2015-2020)
Table 33. Global Bupivacaine Liposome Injectable Suspension Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Bupivacaine Liposome Injectable Suspension Price (K Units) by Type (2015-2020)
Table 35. Global Bupivacaine Liposome Injectable Suspension Sales (K Units) by Type (2021-2026)
Table 36. Global Bupivacaine Liposome Injectable Suspension Sales Share by Type (2021-2026)
Table 37. Global Bupivacaine Liposome Injectable Suspension Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Type (2021-2026)
Table 39. Global Bupivacaine Liposome Injectable Suspension Price (K Units) by Type (2021-2026)
Table 40. Global Bupivacaine Liposome Injectable Suspension Sales (K Units) by Application (2015-2020)
Table 41. Global Bupivacaine Liposome Injectable Suspension Sales Share by Application (2015-2020)
Table 42. Global Bupivacaine Liposome Injectable Suspension Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Bupivacaine Liposome Injectable Suspension Price by Application 2015-2020 (US$/Unit)
Table 44. Global Bupivacaine Liposome Injectable Suspension Sales by Application (2015-2020) (K Units)
Table 45. Global Bupivacaine Liposome Injectable Suspension Sales Share by Application (2015-2020)
Table 46. Global Bupivacaine Liposome Injectable Suspension Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Application (2021-2026)
Table 48. Global Bupivacaine Liposome Injectable Suspension Price (K Units) by Application (2021-2026)
Table 49. North America Bupivacaine Liposome Injectable Suspension Sales by Company (2015-2020) (K Units)
Table 50. North America Bupivacaine Liposome Injectable Suspension Sales Market Share by Company (2015-2020)
Table 51. North America Bupivacaine Liposome Injectable Suspension Sales by Type (2015-2020) (K Units)
Table 52. North America Bupivacaine Liposome Injectable Suspension Sales Market Share by Type (2015-2020)
Table 53. North America Bupivacaine Liposome Injectable Suspension Sales by Application (2015-2020) (K Units)
Table 54. North America Bupivacaine Liposome Injectable Suspension Sales Market Share by Application (2015-2020)
Table 55. North America Bupivacaine Liposome Injectable Suspension Sales by Countries (2015-2020) (K Units)
Table 56. North America Bupivacaine Liposome Injectable Suspension Sales Market Share by Countries (2015-2020)
Table 57. North America Bupivacaine Liposome Injectable Suspension Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Bupivacaine Liposome Injectable Suspension Revenue Market Share by Countries (2015-2020)
Table 59. Europe Bupivacaine Liposome Injectable Suspension Sales by Company (2015-2020) (K Units)
Table 60. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share by Company (2015-2020)
Table 61. Europe Bupivacaine Liposome Injectable Suspension Sales by Type (2015-2020) (K Units)
Table 62. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share by Type (2015-2020)
Table 63. Europe Bupivacaine Liposome Injectable Suspension Sales by Application (2015-2020) (K Units)
Table 64. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share by Application (2015-2020)
Table 65. Europe Bupivacaine Liposome Injectable Suspension Sales by Countries (2015-2020) (K Units)
Table 66. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share by Countries (2015-2020)
Table 67. Europe Bupivacaine Liposome Injectable Suspension Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Bupivacaine Liposome Injectable Suspension Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Bupivacaine Liposome Injectable Suspension Sales by Company (2015-2020) (K Units)
Table 80. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share by Company (2015-2020)
Table 81. Latin America Bupivacaine Liposome Injectable Suspension Sales by Type (2015-2020) (K Units)
Table 82. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share by Type (2015-2020)
Table 83. Latin America Bupivacaine Liposome Injectable Suspension Sales by Application (2015-2020) (K Units)
Table 84. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share by Application (2015-2020)
Table 85. Latin America Bupivacaine Liposome Injectable Suspension Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share by Countries (2015-2020)
Table 87. Latin America Bupivacaine Liposome Injectable Suspension Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Bupivacaine Liposome Injectable Suspension Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue Market Share by Countries (2015-2020)
Table 97. Pacira Pharmaceuticals Company Details
Table 98. Pacira Pharmaceuticals Description and Business Overview
Table 99. Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 100. Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020)
Table 101. Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales Market Share in Global Market
Table 102. Pacira Pharmaceuticals Recent Development
Table 103. Bupivacaine Liposome Injectable Suspension Distributors List
Table 104. Bupivacaine Liposome Injectable Suspension Customers List
Table 105. Global Bupivacaine Liposome Injectable Suspension Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 106. Global Bupivacaine Liposome Injectable Suspension Sales Forecast by Type 2021-2026 (K Units)
Table 107. Global Bupivacaine Liposome Injectable Suspension Sales Forecast by Application 2021-2026 (K Units)
Table 108. Global Bupivacaine Liposome Injectable Suspension Sales Forecast by Regions 2021-2026 (K Units)
Table 109. Global Bupivacaine Liposome Injectable Suspension Revenue Forecast by Regions 2021-2026 (Million US$)
Table 110. North America Bupivacaine Liposome Injectable Suspension Sales Forecast by Countries 2021-2026 (K Units)
Table 111. North America Bupivacaine Liposome Injectable Suspension Revenue Forecast by Countries 2021-2026
Table 112. Europe Bupivacaine Liposome Injectable Suspension Sales Forecast by Countries 2021-2026 (K Units)
Table 113. Europe Bupivacaine Liposome Injectable Suspension Revenue Market Share Forecast by Countries 2021-2026
Table 114. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales Forecast by Regions 2021-2026 (K Units)
Table 115. Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue Forecast by Regions 2021-2026 (Million US$)
Table 116. Latin America Bupivacaine Liposome Injectable Suspension Sales Forecast by Countries 2021-2026 (K Units)
Table 117. Latin America Bupivacaine Liposome Injectable Suspension Revenue Forecast by Countries 2021-2026 (Million US$)
Table 118. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Forecast by Regions 2021-2026 (K Units)
Table 119. Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue Forecast by Regions 2021-2026 (Million US$)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Bupivacaine Liposome Injectable Suspension Product Picture
Figure 2. Global Bupivacaine Liposome Injectable Suspension Sales Market Shar by Type 2015-2026
Figure 3. 20ml Figures
Figure 4. 10ml Figures
Figure 5. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Application in 2019 & 2026
Figure 6. Veterinary Use Case
Figure 7. Human Use Case
Figure 8. Bupivacaine Liposome Injectable Suspension Report Years Considered
Figure 9. Global Bupivacaine Liposome Injectable Suspension Market Size 2015-2026 (Million US$)
Figure 10. Global Bupivacaine Liposome Injectable Suspension Sales 2015-2020 (K Units)
Figure 11. Global Bupivacaine Liposome Injectable Suspension Market Size Market Share by Regions 2015-2020
Figure 12. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Bupivacaine Liposome Injectable Suspension Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Bupivacaine Liposome Injectable Suspension Sales in 2019
Figure 16. Bupivacaine Liposome Injectable Suspension Value Share by Manufacturers in 2019
Figure 17. Bupivacaine Liposome Injectable Suspension Revenue Share by Manufacturers In 2019
Figure 18. Bupivacaine Liposome Injectable Suspension Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Type (2015-2020)
Figure 20. Global Bupivacaine Liposome Injectable Suspension Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Bupivacaine Liposome Injectable Suspension Market Share by Price Range (2015-2020)
Figure 22. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Application (2015-2020)
Figure 23. Global Bupivacaine Liposome Injectable Suspension Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Bupivacaine Liposome Injectable Suspension Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 27. Europe Bupivacaine Liposome Injectable Suspension Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 29. France Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 30. U.K. Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 31. Italy Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 32. Russia Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 33. Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 35. Japan Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 36. South Korea Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 37. India Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 38. Australia Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 39. Taiwan Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 40. Indonesia Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 41. Thailand Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 42. Malaysia Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 43. Philippines Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 44. Vietnam Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 45. Latin America Bupivacaine Liposome Injectable Suspension Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 47. Brazil Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 48. Argentina Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 49. Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 51. Saudi Arabia Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.A.E Bupivacaine Liposome Injectable Suspension Sales Growth Rate (2015-2020) (K Units)
Figure 53. Pacira Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Bupivacaine Liposome Injectable Suspension Value Chain
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. North America Bupivacaine Liposome Injectable Suspension Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 58. North America Bupivacaine Liposome Injectable Suspension Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 59. Europe Bupivacaine Liposome Injectable Suspension Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 60. Europe Bupivacaine Liposome Injectable Suspension Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 61. Asia Pacific Bupivacaine Liposome Injectable Suspension Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 62. Asia Pacific Bupivacaine Liposome Injectable Suspension Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 63. Latin America Bupivacaine Liposome Injectable Suspension Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 64. Latin America Bupivacaine Liposome Injectable Suspension Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 65. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 66. Middle East and Africa Bupivacaine Liposome Injectable Suspension Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


【掲載企業】

Pacira Pharmaceuticals

★調査レポート[世界のブピバカインリポソーム注射懸濁液市場:成長動向・競争分析2020-2026] (コード:QYR20AP00408)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のブピバカインリポソーム注射懸濁液市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆